The market for breast lesion localization methods is expected to grow from USD 413 million in 2018 to USD 598 million by 2024, at a CAGR of 6.3% during the forecast period.
According to the new market research report "Breast Lesion Localization Methods Market by Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2024", published by MarketsandMarkets™.
The overall market for Breast Lesion Localization Methods Market is expected to grow rapidly owing to the increasing number of breast cancer surgeries and increasing awareness on early detection of breast cancer. Furthermore, the demand for improved quality of care and growing awareness among patients about breast cancer screening also contributes to market growth.
However, uncertainty in regulatory approval procedures may negatively affect the market.
Based on type, the Breast Lesion Localization Methods Market is divided into wire localization, isotope localization, magnetic localization, electromagnetic localization, and others. The wire localization segment accounted for the largest share of the Breast Lesion Localization Methods Market in 2018.
The large share of this segment is attributed to the increasing use of third-party independent quality controls due to their benefits such as longer shelf-lives and flexibility across different reagent lots, which help reduce the cost of operations.
Browse and in-depth TOC on "Breast Lesion Localization Methods Market"
67 - Tables
9 - Figures
103 - Pages
By analyte type, the Breast Lesion Localization Methods Market is segmented into tumor identification and sentinel lymph node identification. The sentinel lymph node identification segment is further divided by types of surgery into lumpectomy and mastectomy.
The sentinel lymph node identification segment dominated the Breast Lesion Localization Methods Market in 2018. This segment is expected to grow at the highest rate during the forecast period, mainly due to the increasing acceptance of SLNB as a first-line diagnostic approach for breast cancer staging, as it is more sensitive and causes less morbidity than traditional techniques for the early staging of breast cancer.
In addition, the increasing use of combined localization for non-palpable tumors and sentinel lymph nodes such as ROLL and magnetic localization will drive the growth for this segment.
In 2018, the Asia Pacific held the largest share of the Breast Lesion Localization Methods Market, in terms of volume. In addition to this, Asia Pacific is estimated to grow at the highest CAGR during the forecast period.
The rapidly increasing patient population and healthcare expenditure, improving healthcare infrastructure, high government spending on breast cancer research, and increasing awareness about the importance of the early detection of breast cancer in several APAC countries are supporting the growth of the Asia Pacific Breast Lesion Localization Methods Market.
The prominent players in the Breast Lesion Localization Methods Market are Cianna Medical (US), Endomagnetics Ltd. (UK), and Cook Medical (US), C.R.
Bard (US), Intra-Medical Imaging LLC (US), and IsoAid, LLC (US)
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...